Fertility outcomes subsequent to medical and surgical treatment for ectopic pregnancy: A retrospective cohort study in Iran.

OA: gold CC-BY-NC-4.0
AI-generated summary by gemini-2.5-flash-lite, 2026-08-01

Fertility outcomes, including subsequent intrauterine pregnancy and ectopic pregnancy recurrence, did not significantly differ among women treated with methotrexate, salpingostomy, or salpingectomy for ectopic pregnancy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-24 · read from full text

This retrospective cohort study evaluated fertility outcomes in 194 Iranian women treated for tubal ectopic pregnancy via methotrexate, laparoscopic salpingostomy, or salpingectomy. The researchers found no statistically significant differences among the three treatment modalities regarding subsequent successful intrauterine pregnancies or rates of recurrent ectopic pregnancy. Instead, predictors for successful future conception included multiparity and a history of live births, while nulliparity predicted recurrence. Relevance to endometriosis: Endometriosis is listed as one of several risk factors for developing ectopic pregnancy within the paper's introduction, though the study does not focus on treating the condition itself.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BackgroundEctopic pregnancy (EP) and its treatment methods may affect subsequent fertility outcomes.ObjectiveTo compare methotrexate (MTX), laparoscopic salpingostomy, and salpingectomy methods of EP treatment and their effects on fertility outcomes.Materials and methodsThis retrospective cohort study was performed on women receiving a definitive diagnosis of tubular EP from 2014 to 2017 at Arash Medical Center, Tehran, Iran. In total, 194 women were studied, of which 64 were treated with MTX, 52 underwent salpingostomy, and 78 underwent salpingectomy, depending on their clinical status. Basic information, obstetrics history, and major outcomes of the treatment after an 18-month follow-up, including recurrence of EP, miscarriage, and successful intrauterine pregnancy (IUP), were recorded and variables were compared among the three groups.ResultsThere was no significant difference in fertility outcomes among the three groups. Among the studied variables, predictors of successful IUP after EP treatment were multiparity (Hazard Ratio (HR): 1.37; 95%CI: 1.06-1.77), no history of miscarriage (HR: 2.37; 95%CI: 1.01-5.56), and a higher number of live births (HR: 1.54; 95%CI: 1.01-2.37). On the other hand, predictors of EP recurrence included nulliparity (HR: 1.61; 95%CI: 1.02-2.53) and a lower number of live births (HR: 3.84; 95%CI: 1.43-10.98). The effect of other factors, including the utilized therapeutic modalities, was not statistically significant.ConclusionThe current study results demonstrated that after an 18-month follow-up, fertility outcomes, including recurrence of EP and successful IUP, were not significantly different among the subjects with EP treated with MTX, salpingostomy, or salpingectomy. Further studies with long-term follow-ups are recommended.
Full text 15,607 characters · extracted from pmc-nxml · 2 sections · click to expand

Section

The results of the current study demonstrated that with an 18-month follow-up, fertility outcomes, including recurrence of EP and successful IUP, were not significantly different among women with EP treated with MTX, salpingostomy, or salpingectomy. Further studies with longer-term follow-ups are recommended.

Coi Statement

The authors declare no conflict of interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-30T09:23:35.175841+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-4.0